Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
Quick Stats
Jan 30, 202651.0
AI Score
HOLD0.98
Volume Ratio
Next Earnings
11
+ve Days (30d)
18
-ve Days (30d)
TCRT Stock Summary
Last updated Jan 30, 2026
TCRT is currently trading at $2.63, positioned below its 200-day moving average of $3.03, suggesting bearish momentum. The stock has a 52-week range of $1.3137 to $6.2.
Technical Analysis: The 50-day moving average stands at $3.36, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 36.931, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.274, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates TCRT at 51.0/100 with a HOLD recommendation.
TCRT (Alaunos Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 36.931 |
| CMF (20) | -0.274 |
| ROC (10) | -6.406 |
| ADX (14) | 13.862 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.165 |
| AROONOSC (14) | -100.0 |
| WILLAMS %R (14) | -94.915 |
| MFI (14) | 29.638 |
TCRT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TCRT Price vs Max Options Open Interest
TCRT Max Change In Options Open Interest
TCRT Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TCRT Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TCRT Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TCRT Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Alaunos Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
TCRT Moving Averages Analysis
TCRT (Alaunos Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.89 |
| 20 | 2.98 |
| 30 | 3.16 |
| 50 | 3.36 |
| 100 | 3.05 |
| 200 | 3.03 |
TCRT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 6.2 million |
| Earnings/Share ($) | -2.3 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0 |
| EPS Estimate Next Year ($) | 0 |
| WallStreet Target Price ($) | 1.75 |
| Most Recent Quarter |